£500K
The seed round was led by Parkwalk Advisors and includes backing from Amadeus Capital Partners, Crista Galli, RCA, and Oxbridge Angels to fund the market launch of the CUE1 device.
CN
Charco Neurotech
Charco Neurotech develops wearable technology to manage Parkinson symptoms.
London, UK—Founded 2019
£500KTotal raised
Charco Neurotech develops non-invasive wearable medical devices designed to help manage symptoms for people with Parkinson disease. The team brings together designers, engineers, and medical professionals to create accessible health solutions.
Categories
Founders
Lucy Jung
CEO and Co-founder
Lucy serves as chief executive and co-founder of Charco Neurotech. She also teaches at Oxford Royale and lectures at Imperial College London.
LinkedIn
Floyd Pierres
Co-founder
Floyd is a medical registrar and co-founder at Charco Neurotech, alongside clinical experience within the NHS.
LinkedIn